Cargando…

503. Post-vaccination SARS-CoV-2 Infections and Immune Response in People with Immune Disorders

BACKGROUND: While some immune-deficient persons (IDP) face higher risk for severe SARS-CoV-2 infection than the general population, little is known about their immune response to post-vaccination infections. METHODS: A cohort of 217 IDP and 54 healthy volunteers (HV) were followed from April 2021 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zendt, Mackenzie, Carrillo, Fausto Bustos, Subramanian, Rahul, Callier, Viviane, Ortega-Villa, Ana, Ricotta, Emily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677684/ http://dx.doi.org/10.1093/ofid/ofad500.572

Ejemplares similares

Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies
por: Zendt, Mackenzie, et al.
Publicado: (2023)

503 Peculiarities of Immune Response in Young Children with Recurrent Wheezing
por: Gromadina, Olga, et al.
Publicado: (2012)

Poster Sessions 313-503
Publicado: (2004)

LncRNA ZNF503-AS1 promotes RPE differentiation by downregulating ZNF503 expression
por: Chen, Xue, et al.
Publicado: (2017)

Undetectable SARS-CoV-2 active adaptive immunity—post-vaccination or post-COVID-19 severe disease—after immunosuppressants use
por: Adedoyin, Oluwafeyi, et al.
Publicado: (2021)

Effect of miR-503 Down-Regulation on Growth and Invasion of Esophagus Carcinoma and Related Immune Function
por: Zhao, Ke, et al.
Publicado: (2015)

Treatment of 503 cattle with traumatic reticuloperitonitis
por: Braun, Ueli, et al.
Publicado: (2018)

Mesenchymal stem cells shuttling miR-503 via extracellular vesicles enhance glioma immune escape
por: Wang, Xiao-Song, et al.
Publicado: (2021)

SARS-CoV-2 immunity and vaccine strategies in people with HIV
por: Mullender, Claire, et al.
Publicado: (2022)

Scientific opinion of Flavouring Group Evaluation 503 (FGE.503): grill flavour ‘Grillin’ CB‐200SF’
por: Silano, Vittorio, et al.
Publicado: (2017)

Endemic SARS-CoV-2 will maintain post-pandemic immunity
por: Veldhoen, Marc, et al.
Publicado: (2021)

IMMUNE THROMBOCYTOPENIA PURPURA FLARE POST SARS-COV-2 VACCINATION
por: Ali, Elrazi, et al.
Publicado: (2021)

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses
por: Hopkins, Kathryn L., et al.
Publicado: (2014)

Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection
por: Merli, Michele, et al.
Publicado: (2020)

SARS-CoV-2 hybrid immunity: silver bullet or silver lining?
por: Suryawanshi, Rahul, et al.
Publicado: (2022)

Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
por: Carrillo, Jorge, et al.
Publicado: (2021)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

Clinical and laboratory findings in 503 cattle with traumatic reticuloperitonitis
por: Braun, Ueli, et al.
Publicado: (2018)

Adaptive Immune Responses and Immunity to SARS-CoV-2
por: Primorac, Dragan, et al.
Publicado: (2022)

Machine learning in evolutionary studies comes of age
por: Callier, Viviane
Publicado: (2022)

Evolutionary and structural analysis of SARS-CoV-2 specific evasion of host immunity
por: Hussain, Irfan, et al.
Publicado: (2020)

Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV
por: Bessen, Clara, et al.
Publicado: (2022)

M191 IMMUNE ASSESSMENT IN POST-ACUTE SEQUALA OF SARS-COV2 INFECTION (PASC): EVIDENCE OF PERSISTENT IMMUNE ACTIVATION?
por: Ahluwalia, V., et al.
Publicado: (2021)

Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients—a perspective
por: Hammarström, Lennart, et al.
Publicado: (2020)

Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
por: Delmonte, Ottavia M., et al.
Publicado: (2021)

SARS-CoV-2: from herd immunity to hybrid immunity
por: Goldblatt, David
Publicado: (2022)

Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants
por: Subramanian, Vijay
Publicado: (2023)

Optics studies based on V6.503 nominal configuration
por: Aiba, M, et al.
Publicado: (2009)

503. The Misappropriation of COVID-19 Related TV Ad Expenditures
por: Vyas, Kartavya J
Publicado: (2020)

Immune Dysregulation in Acute SARS-CoV-2 Infection
por: Grimm, Lauren, et al.
Publicado: (2023)

SARS-CoV-2 post-infective myocarditis: the tip of COVID-19 immune complications?
por: Tissières, Pierre, et al.
Publicado: (2020)

Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infection
por: Newell, Krista L, et al.
Publicado: (2022)

Immune Response after SARS-CoV-2 Infection with Residual Post-COVID Symptoms
por: Pongkunakorn, Tanyaporn, et al.
Publicado: (2023)

PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response
por: Loretelli, Cristian, et al.
Publicado: (2021)

Host cell-intrinsic innate immune recognition of SARS-CoV-2
por: Madden, Emily A, et al.
Publicado: (2022)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

Adaptive immunity to SARS-CoV-2
por: Altmann, Daniel M
Publicado: (2020)

T cell immunity to SARS-CoV-2
por: Niessl, Julia, et al.
Publicado: (2021)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity
por: Achdout, Hagit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_reijotao2d0lvq2di23dc6ptk0